2022-05-19 07:05:47 REVE Alpine Acquisition
05/19/22 05/1907:05 05/19/2207:05 | Alpine Acquisition enters agreements to acquire Two Bit Circus, two hotelsAlpine Acquisition Corporation and Two Bit Circus announced that they have entered into definitive agreements for a business combination. Alpine also entered into a definitive agreement with affiliates of Atrium Hospitality, LP, to acquire two full-service conference hotels with 739 rooms and 135,000 square feet of conference facilities located in Denver, CO and Stamford, CT. Upon the closing of the transactions, Alpine will acquire Two Bit Circus and the hotels and commence transformational renovations of both properties. The properties will be rebranded to Revelers Resorts, using Two Bit Circus's proprietary technology and entertainment experiences. The combined company is expected to be renamed "Two Bit Entertainment Corp." and continue to be listed on NASDAQ under the symbol REVE. The transactions are expected to close in the 3rd quarter of 2022. The new entertainment brand, Revelers Resorts, will provide inclusive activities along with an immersive story experience woven throughout the entire resort; Circus adventures, STEAM games and workshop activities bring to life the Reveler's world. Full food and beverage offerings are expected to include Plate Spinner Pizza and a Cannonball Candy Shop along with carnival carts with signature treats. Revelers Resort will also have one of a kind social play attractions and other games, such as a reimagined arcade and midway for upleveled play throughout Reveler's Circus Grounds area. Purchasing existing conference center hotels in strong demographic locations at deep discounts to their replacement costs is expected to allow the new brand to quickly enter new markets, provide affordable entertainment and lodging accommodations, and grow quickly and profitably. These hotels already have the full-service amenities needed to adapt and renovate to the new brand along with leveraging the Two Bit Circus' immersive-fueled experiential entertainment technology to create Revelers Resorts. Two Bit Circus shareholders will contribute 100% of their equity into the combined company. Alpine will issue an aggregate of 4,980,000 shares of common stock to the Two Bit Circus shareholders and 1,950,000 shares of common stock to the sellers of the hotels being acquired. The boards of directors of Alpine and Two Bit Circus have approved the proposed business combination. Completion of the proposed business combination is subject to approval by Alpine's stockholders and the satisfaction or waiver of other customary closing conditions. $50 million all stock transaction from Alpine Acquisition Corporation for Two Bit Circus, Inc.; $65 million cash and stock purchase of two full-service conference hotels with 739 rooms and over 140,000 square feet of conference facilities located in Denver, CO and Stamford, CT; Transactions expected to close in the third quarter of 2022. |
---|
Upgrade
|
Pirelli upgraded to Overweight from Equal Weight at Morgan Stanley »
04:46 02/03/23 02/0304:46 02/03/2304:46
PLLIF
Pirelli
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
SSAB AB downgraded to Equal Weight from Overweight at Morgan Stanley »
04:44 02/03/23 02/0304:44 02/03/2304:44
SSAAY
SSAB AB
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Friedrich Vorwerk downgraded to Hold from Buy at Berenberg »
04:43 02/03/23 02/0304:43 02/03/2304:43
FRVWY
Friedrich Vorwerk
Berenberg analyst Lasse… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Asos downgraded to Hold from Buy at Deutsche Bank »
04:40 02/03/23 02/0304:40 02/03/2304:40
ASOMY
Asos
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Pets at Home Group downgraded to Hold from Buy at Deutsche Bank »
04:39 02/03/23 02/0304:39 02/03/2304:39
PAHGF
Pets at Home Group
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Kingfisher downgraded to Hold from Buy at Deutsche Bank »
04:39 02/03/23 02/0304:39 02/03/2304:39
KGFHY
Kingfisher
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Inditex upgraded to Hold from Sell at Deutsche Bank »
04:38 02/03/23 02/0304:38 02/03/2304:38
IDEXY
Inditex
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
B&M European Value Retail upgraded to Buy from Hold at Deutsche Bank »
04:37 02/03/23 02/0304:37 02/03/2304:37
BMRRY
B&M European Value Retail
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Marks & Spencer upgraded to Buy from Hold at Deutsche Bank »
04:37 02/03/23 02/0304:37 02/03/2304:37
MAKSY
Marks & Spencer
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Standard Chartered upgraded to Buy from Hold at Investec »
04:34 02/03/23 02/0304:34 02/03/2304:34
SCBFF
Standard Chartered
Investec analyst Ian… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Amazon.com price target raised to $123 from $119 at Piper Sandler »
04:32 02/03/23 02/0304:32 02/03/2304:32
AMZN
Amazon.com
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Alphabet price target lowered to $120 from $122 at Piper Sandler »
04:30 02/03/23 02/0304:30 02/03/2304:30
GOOGL
Alphabet
Alphabet
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Gilead price target raised to $112 from $111 at Piper Sandler »
04:28 02/03/23 02/0304:28 02/03/2304:28
GILD
Gilead
Piper Sandler analyst Do… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Conmed price target raised to $118 from $108 at Piper Sandler »
04:27 02/03/23 02/0304:27 02/03/2304:27
CNMD
Conmed
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Privia Health initiated with a Buy at Goldman Sachs »
04:26 02/03/23 02/0304:26 02/03/2304:26
PRVA
Privia Health
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Agios Pharmaceuticals initiated with an Overweight at Piper Sandler »
04:25 02/03/23 02/0304:25 02/03/2304:25
AGIO
Agios Pharmaceuticals
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
General news
| Market Update: Asian… Story temporarily locked. ShowHide Related Items >><<
|
General news
|
China economy bounces back thanks to services. »
02:25 02/03/23 02/0302:25 02/03/2302:25
$ECON
Economic Data
China economy bounces… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Piper Sandler economist to hold an analyst/industry conference call »
22:33 02/02/23 02/0222:33 02/02/2322:33
Chief Economist Lazar and… Chief Economist Lazar and Head of Global Policy Perli discuss payrolls and their implications on an Analyst/Industry conference call to be held on February 3 at 8:45 am. Webcast Link |
Conference/Events
|
Cowen medical devices analyst to hold analyst/industry conference call »
22:24 02/02/23 02/0222:24 02/02/2322:24
Medical Devices Analyst… Medical Devices Analyst Jennings, along with Dr. Shephal Doshi, Director of Cardiac Electrophysiology at Pacific Heart Institute, discuss the market dynamics of the U.S. Left Atrial Appendage Closure (LAAC) Duopoly on an Analyst/Industry conference call to be held on February 7 at 12:30 pm. Webcast Link |
Syndicate
|
Avalo Therapeutics 3.77M share Spot Secondary priced at $3.98 »
21:56 02/02/23 02/0221:56 02/02/2321:56
AVTX
Avalo Therapeutics
SVB Securities and RBC… SVB Securities and RBC Capital are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Recommendations
|
Conmed price target raised to $118 from $108 at Piper Sandler »
21:55 02/02/23 02/0221:55 02/02/2321:55
CNMD
Conmed
Piper Sandler analyst… Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $118 from $108 and keeps an Overweight rating on the shares. The company unsurprisingly missed on Q4 earnings and revenue due to a previously disclosed Software Implementation issue, but this should be a transitory factor, the analyst tells investors in a research note. Conmed's key growth drivers - the Smoke business, In2Bones and Biorez - remain strong and should stay that way through 2023 and beyond, the firm adds. ShowHide Related Items >><<
|
Syndicate
|
Roivant Sciences 26.67M share Secondary priced at $7.50 »
21:17 02/02/23 02/0221:17 02/02/2321:17
ROIV
Roivant Sciences
The deal size was… The deal size was increased to $200M from $150M and priced below last closing price of $7.59. Goldman Sachs, SVB Securities, Cowen and Cantor Fitzgerald are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Syndicate
|
Edible Garden 1.62M share Spot Secondary priced at $6.30 »
20:43 02/02/23 02/0220:43 02/02/2320:43
EDBL
Edible Garden
The deal priced below… The deal priced below last closing price of $8.35. Maxim and Joseph Gunnar are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Hot Stocks
|
Dutch Bros CEO sells $6.0M in common stock »
20:39 02/02/23 02/0220:39 02/02/2320:39
BROS
Dutch Bros
In a regulatory filing,… In a regulatory filing, Dutch Bros disclosed that its CEO Jonathan Ricci sold 160K shares of common stock on February 1 in a total transaction size of $6.0M. ShowHide Related Items >><<
|